Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15.
about
Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications.Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL.IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cellsHuman fused NKG2D-IL-15 protein controls xenografted human gastric cancer through the recruitment and activation of NK cells.The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8+ T cells for adoptive immunotherapy of cancer and infections.Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma.Developmental and Functional Control of Natural Killer Cells by Cytokines.Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease.Subset- and tissue-defined STAT5 thresholds control homeostasis and function of innate lymphoid cellsSmad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development.Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cellsChimeric antigen receptor-engineered primary natural killer cells: a tool to improve adoptive tumor immunotherapy.Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.Lymph Node Cellular and Viral Dynamics in Natural Hosts and Impact for HIV Cure Strategies.Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
P2860
Q35600095-8C1FEB6A-02DF-4931-A061-33AB6704F481Q35711209-6BB26109-7465-4C0C-8491-68CF2119CF75Q37101299-9EB56F21-0A0C-451B-93D9-EBD32DA80D11Q37261189-83BA57B3-5516-48EA-9B65-E14C40C5336BQ37474007-CC25B35D-4FA4-4B13-80C2-EDC56CA8D922Q37714638-58A7EEBD-A3BE-459F-96E7-185F38B210DEQ38670431-3E39B9F7-1497-4470-AA0D-22FC2B93852AQ38768298-67D07FA1-3D77-4C04-B934-23D6A1A67AE3Q38784430-376B755F-C83E-4EF7-9894-4C5F37DADFA2Q40086298-1EA998D5-BFC0-4810-BBE4-134355758876Q41348755-C7715CEC-6264-4B19-9C75-099C25372D47Q41761867-76CB0EAF-71AC-4EBF-AB3C-88D5CF1F1197Q42317402-5B6E2A1C-68DE-4FFD-861A-CA311DAA802FQ42556477-8E2B4E7C-83B4-41EC-BC99-6B33B5E1E99BQ51219083-D7BC4256-82B8-4C2F-9904-ADF36BB66FC1Q53705286-91C0387B-06C4-4338-B589-72615A2AAA24Q55260301-E6B1809A-61FD-4454-965C-A3FAE17A9523Q57300237-AFD18773-8DEF-4159-88AB-C690B9951F42
P2860
Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Autonomous growth and increase ...... membrane-bound interleukin-15.
@en
type
label
Autonomous growth and increase ...... membrane-bound interleukin-15.
@en
prefLabel
Autonomous growth and increase ...... membrane-bound interleukin-15.
@en
P2093
P1433
P1476
Autonomous growth and increase ...... membrane-bound interleukin-15.
@en
P2093
Chihaya Imai
Dario Campana
David Shook
Elaine Coustan-Smith
Masaru Imamura
Noriko Shimasaki
Sally M H Chai
Takahiro Kamiya
P304
P356
10.1182/BLOOD-2014-02-556837
P407
P577
2014-07-08T00:00:00Z